Can Mounjaro Cause Dry Eyes? What We Know

You've noticed your eyes feel drier since starting the pen, here's the honest picture

You're a few weeks into Mounjaro and your eyes feel scratchy in a way they didn't before. It's a reasonable thing to wonder about. If you want to understand the specific relationship between the medicine and ocular dryness, our page on Mounjaro dry eyes goes into the detail behind what the evidence does and doesn't show. The short answer: dry eyes do not appear as a named adverse reaction in Mounjaro's UK Summary of Product Characteristics, which is the definitive clinical reference reviewed and approved by regulators. That document lists the side effects identified during tirzepatide's clinical programme, and dry eyes are not among them. The NHS tirzepatide medicines page reflects this picture, covering the common, uncommon and rare effects identified in trials without flagging ocular dryness.

That doesn't mean your experience isn't real. Post-marketing surveillance (the ongoing monitoring that happens once a medicine is in widespread use) sometimes surfaces patterns that large controlled trials, with their specific populations and endpoints, don't catch. Some people do report eye dryness or irritation on forums and through yellow-card-style reporting systems. The question is what's driving it.

Worth doing now: blink deliberately ten times, then look away from any screen for twenty seconds. If the grittiness eases, screen exposure and reduced blink rate are likely contributors rather than the medicine itself. A small, quick test that takes no equipment and under a minute.

For a fuller look at ocular symptoms on tirzepatide more broadly, our page on Mounjaro and eye symptoms covers the wider picture.

Why weight-loss treatment can affect the eyes, even when it isn't the direct cause

Mounjaro works by activating two gut-hormone receptors, GIP and GLP-1, which slow gastric emptying and reduce appetite substantially. When appetite falls and calorie intake drops, people sometimes eat and drink differently: less omega-3-rich food, less overall fluid intake, more fatigue-driven screen time. All three can affect the tear film.

Tear film quality depends partly on nutritional status. Omega-3 fatty acids, found in oily fish, walnuts and flaxseed, contribute to the lipid layer that stops tears evaporating too quickly. A reduced-calorie diet that cuts these foods without replacing them can tip the balance. Dehydration (another common experience in the early weeks of treatment when nausea is highest) also reduces tear production.

There's a separate consideration for people who had undiagnosed or poorly controlled blood sugar before starting Mounjaro. As blood glucose stabilises, the lens of the eye can change shape temporarily, which occasionally shows up as blurring or sensitivity. This is distinct from dryness, though the two can feel similar, and our page on whether Mounjaro causes dry mouth explores how the medicine can affect moisture levels in related ways that may help explain the broader pattern. People managing type 2 diabetes alongside weight treatment should let their ophthalmologist know they've started tirzepatide.

Dryness-adjacent symptoms are common enough across weight-loss treatments generally that our page comparing Mounjaro and dry skin covers some of the same systemic nutritional factors, if that context is useful.

When an eye symptom during Mounjaro treatment needs medical attention today

Most reports of dry or tired eyes in people on Mounjaro settle without intervention, especially once the early nausea phase passes and eating patterns stabilise. But some eye symptoms during GLP-1 treatment warrant same-day medical contact rather than a wait-and-see approach.

Sudden changes in vision (blurring that comes on quickly, flashes, floaters, a new dark area in your field of view) need urgent attention. This is particularly relevant for people with a history of diabetic retinopathy, which can, in rare cases, worsen early in the course of intensive blood-glucose management. Some patients also ask broader questions about neurological symptoms, and our page on whether Mounjaro can cause MS addresses one of the more common concerns we hear about the medicine's relationship with the nervous system. The MHRA Yellow Card scheme exists precisely so that patients and clinicians can report unexpected effects and help build a clearer picture of what's happening in the real-world population.

Persistent dry eyes that don't respond to lubricating drops after two to three weeks, or dryness accompanied by redness, pain, light sensitivity or discharge, also need a clinician's eyes on them, literally. These could reflect an unrelated condition that Mounjaro's appetite-suppressing effect has simply made easier to notice.

If you're uncertain whether what you're experiencing counts, our team is reachable through our contact page, and our prescribers can advise. You can also learn more about the service and who reviews patients at our clinical team profile.

Thinking about whether Mounjaro could be right for you, or whether you're already on it and want clinical support? The starting point is a free consultation, where a GPhC-registered prescriber reviews your full picture (conditions, medications, history) not just your BMI. Start your free consultation to speak with our team.